|
1
|
Škamperle M, Kocjan BJ, Maver PJ, Seme K
and Poljak M: Human papillomavirus (HPV) prevalence and HPV type
distribution in cervical, vulvar, and anal cancers in central and
eastern Europe. Acta Dermatovenerol Alp Pannonica Adriat. 22:1–5.
2013.PubMed/NCBI
|
|
2
|
Voidăzan S, Tarcea M, Morariu SH, Grigore
A and Dobreanu M: Human papillomavirus vaccine - knowledge and
attitudes among parents of children aged 10–14 years: A
cross-sectional study, Tirgu Mures, Romania. Cent Eur J Public
Health. 24:29–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salavastru CM, Niculescu MC, Zota A,
Nicola G, Morariu HS, Solovan C, Patrascu V, Popovici G, Vladuta R,
Panduru M, et al: Epidemiological aspects of genital warts in
romania - a 2012 retrospective survey. Maedica (Buchar). 9:144–150.
2014.PubMed/NCBI
|
|
4
|
Gravitt PE, Peyton CL, Alessi TQ, Wheeler
CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR and Apple RJ:
Improved amplification of genital human papillomaviruses. J Clin
Microbiol. 38:357–361. 2000.PubMed/NCBI
|
|
5
|
Raţiu MP, Purcărea I, Popa F, Purcărea VL,
Purcărea TV, Lupuleasa D and Boda D: Escaping the economic turn
down through performing employees, creative leaders and growth
driver capabilities in the Romanian pharmaceutical industry.
Farmacia. 59:119–130. 2011.
|
|
6
|
Satterwhite CL, Torrone E, Meites E, Dunne
EF, Mahajan R, Ocfemia MC, Su J, Xu F and Weinstock H: Sexually
transmitted infections among US women and men: Prevalence and
incidence estimates, 2008. Sex Transm Dis. 40:187–193. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Owusu-Edusei K Jr, Chesson HW, Gift TL,
Tao G, Mahajan R, Ocfemia MC and Kent CK: The estimated direct
medical cost of selected sexually transmitted infections in the
United States, 2008. Sex Transm Dis Mar. 40:197–201. 2013.
View Article : Google Scholar
|
|
8
|
Workowski KA and Berman S: Centers for
Disease Control and Prevention (CDC): Sexually transmitted diseases
treatment guidelines, 2010. MMWR Recomm Rep. 59(RR-12): 1–110.
2010.PubMed/NCBI
|
|
9
|
Koshiol J, Lindsay L, Pimenta JM, Poole C,
Jenkins D and Smith JS: Persistent human papillomavirus infection
and cervical neoplasia: A systematic review and meta-analysis. Am J
Epidemiol. 168:123–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Louvanto K, Rintala MA, Syrjänen KJ,
Grénman SE and Syrjänen SM: Genotype-specific persistence of
genital human papillomavirus (HPV) infections in women followed for
6 years in the Finnish Family HPV Study. J Infect Dis. 202:436–444.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kjær SK, Frederiksen K, Munk C and Iftner
T: Long-term absolute risk of cervical intraepithelial neoplasia
grade 3 or worse following human papillomavirus infection: Role of
persistence. J Natl Cancer Inst. 102:1478–1488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Syrjänen K, Shabalova I, Naud P,
Kozachenko V, Derchain S, Zakharchenko S, Roteli-Martins C,
Nerovjna R, Longatto-Filho A, Kljukina L, et al: NIS and LAMS Study
Research Groups: Risk estimates for persistent high-risk human
papillomavirus infections as surrogate endpoints of progressive
cervical disease critically depend on reference category: Analysis
of the combined prospective cohort of the New Independent States of
the Former Soviet Union and Latin American Screening studies. Int J
STD AIDS. 22:315–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li N, Franceschi S, Howell-Jones R,
Snijders PJ and Clifford GM: Human papillomavirus type distribution
in 30,848 invasive cervical cancers worldwide: Variation by
geographical region, histological type and year of publication. Int
J Cancer. 128:927–935. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mammas IN and Spandidos DA: Fighting
against human papillomavirus: the 25-year old contribution of the
University of Crete School of Medicine. J BUON. 20:17–21.
2015.PubMed/NCBI
|
|
15
|
Clifford GM, Gonçalves MA and Franceschi
S: HPV and HIV Study Group: Human papillomavirus types among women
infected with HIV: A meta-analysis. AIDS. 20:2337–2344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Du J, Nordfors C, Ährlund-Richter A,
Sobkowiak M, Romanitan M, Näsman A, Andersson S, Ramqvist T and
Dalianis T: Prevalence of oral human papillomavirus infection among
youth, Sweden. Emerg Infect Dis. 18:1468–1471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giraldo P, Gonçalves AK, Pereira SA,
Barros-Mazon S, Gondo ML and Witkin SS: Human papillomavirus in the
oral mucosa of women with genital human papillomavirus lesions. Eur
J Obstet Gynecol Reprod Biol. 126:104–106. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Termine N, Giovannelli L, Matranga D,
Caleca MP, Bellavia C, Perino A and Campisi G: Oral human
papillomavirus infection in women with cervical HPV infection: New
data from an Italian cohort and a metanalysis of the literature.
Oral Oncol. 47:244–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Marco F: Oxidative stress and HPV
carcinogenesis. Viruses. 5:708–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kofoed K, Sand C, Forslund O and Madsen K:
Prevalence of human papillomavirus in anal and oral sites among
patients with genital warts. Acta Derm Venereol. 94:207–211. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Căruntu C, Grigore C, Căruntu A,
Diaconeasa A and Boda D: The role of stress in skin disease. Intern
Med. 8:73–84. 2011.
|
|
22
|
Fang CY, Miller SM, Bovbjerg DH, Bergman
C, Edelson MI, Rosenblum NG, Bove BA, Godwin AK, Campbell DE and
Douglas SD: Perceived stress is associated with impaired T-cell
response to HPV16 in women with cervical dysplasia. Ann Behav Med.
35:87–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spandidos DA: A unified theory for the
development of cancer. Biosci Rep. 6:691–708. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Spandidos DA: The cancer story. Cancer
Biol Ther. 3:1184–1186. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016.PubMed/NCBI
|
|
26
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013. View Article : Google Scholar
|
|
27
|
Wu DW, Chuang CY, Lin WL, Sung WW, Cheng
YW and Lee H: Paxillin promotes tumor progression and predicts
survival and relapse in oral cavity squamous cell carcinoma by
microRNA-218 targeting. Carcinogenesis. 35:1823–1829. 2014.
View Article : Google Scholar : PubMed/NCBI
|
